Our Philosophy: Quality and Patients First.
Ranbaxy Laboratories Limited (Ranbaxy) is a research based international pharmaceutical company serving customers in over 150 countries. For more than 50 years, we have been providing high quality, affordable medicines trusted by healthcare professionals and patients across geographies.
Ranbaxy is a member of the Daiichi Sankyo Group. Daiichi Sankyo is a leading global pharma innovator, headquartered in Tokyo, Japan.
Doctors Speak on World Heart Day
Milkha Singh launches Ranbaxy Diabetes Care Program Business Standard
Nov 09, 2013: Legendary athlete Milkha Singh today launched the Ranbaxy Diabetes Care program at annual conference of the Research Society for Study of Diabetes in India (RSSDI) being held at India Expo Centre...
Ranbaxy gets CDSCO nod to sell malaria drug 'Synriam TM' The Economic Times
Oct 21, 2013: Drug major Ranbaxy Laboratories BSE 0.60 % today said it has received Indian drug regulator's approval to market SynriamTM for treating malaria caused by Plasmodium vivax parasite...
Ranbaxy gets nod to sell new malaria drug The Hindu Business Line
Oct 21, 2013: Ranbaxy Laboratories Ltd has received an approval from the Central Drugs Standard Control Organisation to manufacture and market a new drug for the treatment of malaria in adults...
1 pill for 2 sting parasites The Telegraph
Oct 21, 2013: A new synthetic molecule launched by an Indian drug company last year against malaria caused by the Plasmodium falciparum parasite has now also been approved by India’s drug regulators to treat Plasmodium vivax malaria...
Ranbaxy gets Indian drug regulator's nod to sell malaria drug Hindustan Times
Oct 21, 2013: Drug major Ranbaxy Laboratories today said it has received Indian drug regulator's approval to market Synriam TM for treating malaria caused by Plasmodium vivax parasite...
Ranbaxy drugs safe: India regulator Hindu Business Line
Sept 20, 2013: The Indian drugs regulator is confident about the medicines produced by Ranbaxy that are in circulation in the domestic market. Drugs Controller General of...
No major violations at Ranbaxy's Mohali plant: India's drug regulator Livemint
Sept 20, 2013: India’s drug regulator on Thursday said it found no major discrepancies at Ranbaxy Laboratories Ltd’s manufacturing plant in Mohali...
RANBAXY COMPLETES 20 YEARS IN UKRAINE
Nov 20, 2013:
Gurgaon, India; Kiev, Ukraine: Ranbaxy Laboratories Limited (Ranbaxy), India’s largest pharmaceutical company, is celebrating its 20th anniversary in Ukraine. Establishing…
Ranbaxy Q3 CY 2013 Sales Rs.27.5 Bn. YTD Sep 2013 Sales Rs.77.5 Bn
Oct 29, 2013:
Gurgaon, India: The Board of Directors of Ranbaxy Laboratories Limited (RLL, NSE: RANBAXY, BSE: 500359), at its meeting held today,…
RANBAXY RECEIVES PARAGRAPH IV CERTIFICATION
Sep 19, 2013:
Gurgaon, India: Ranbaxy Laboratories Inc. (RLI), a wholly owned subsidiary of Ranbaxy Laboratories Limited, today announced that the company has…
Sep 17, 2013:
Gurgaon, India: Ranbaxy Laboratories Limited, said today that during the late hours of September 16, 2013, the Company received communication…
RANBAXY COMPLETES 20 YEARS IN RUSSIA
Sep 05, 2013:
Ranked No. 1 in the represented market Gurgaon, India; Moscow, Russia: India’s largest pharmaceutical company, Ranbaxy Laboratories Limited (Ranbaxy) today…
RANBAXY ALLOCATED SITE FOR ITS GREENFIELD MANUFACTURING FACILITY IN MALAYSIA
Aug 08, 2013:
AGREEMENT SIGNED WITH KULIM HI TECH PARK Kuala Lumpur, Malaysia; Gurgaon, India: Ranbaxy Malaysia Sdn Bhd (RMSB) today announced that…